Le Lézard
Classified in: Health, Science and technology
Subject: FVT

AMPLEXOR's March Webinar Program Addresses Major Life Sciences Challenges - Ensuring Patient Safety in Localization and Achieving Best Practice in Regulatory Master Data Management


BROOMFIELD, Colo., March 20, 2018 /PRNewswire/ -- The Life Sciences division of AMPLEXOR, a leading provider of digital experience and compliance solutions, has announced its March 2018 webinar program, with two webinars that aim to address challenges facing those in the life sciences industry.

AMPLEXOR corporate logo (PRNewsfoto/AMPLEXOR Life Sciences)

The latest webinar program is a continuation of AMPLEXOR's commitment to open dialogues about issues that impact the life sciences industry, as Elvis Pa?elat, Executive Vice President, Life Sciences, AMPLEXOR, explains:

"All AMPLEXOR webinars aim to address industry issues that matter most in life sciences, based on discussions with our clients and industry experts. We want our online delivery platform to engage attendees in a practical and informative manner, and anyone in life sciences who seeks to understand translations and localization and master data management strategies is encouraged to attend the webinars this month."

The first webinar (22 March), 'Regulatory Master Data Management ? Best Practices to Get It Right', presented by Romuald Braun, Vice President, Strategy, AMPLEXOR, will explore and review the key challenges organizations face in addressing regulatory Master Data Management (MDM) and offer strategies to help overcome them. 

The second webinar (23 March), 'Breaking Cultural Barriers to Ensure Patient Safety: Localization 101', presented by AMPLEXOR's Kathleen O'Brien, will provide attendees with practical tips and strategies on the best ways to translate and localize content, saving time and resources and ensuring patient safety.

For more information about AMPLEXOR events and webinars, click here.

About the Presenters
Kathleen O'Brien, Director of Business Development - AMPLEXOR Life Sciences
A 15-year veteran of the translation industry, Kathleen has a background in linguistics and has held various roles in the translation business: vendor, project and account management, as well as new business development. Her diverse experience has afforded her with a unique perspective into both translation operations and how translation impacts the globalization needs of her clients in the pharmaceutical and medical device industries. She proactively collaborates with her life sciences client partners on a daily basis to help them set their localization strategies.  Kathleen is based in the Greater NYC area and is an active volunteer of the Healthcare Businesswomen's Association (HBA) and the Life Sciences Trainers & Educators Network (LTEN).

Romuald Braun, Vice President, Strategy - AMPLEXOR Life Sciences
Romuald's 25-year career to date has been spent across roles related to Compliance, Document Management, Content Management in the life sciences industry ? both on the client side and in consulting, spanning delivery, sales, project and line manager roles. His experiences bridge on-premise and cloud environments, in Europe and in US.

For further information, please visit www.amplexor.com

About AMPLEXOR Life Sciences

AMPLEXOR Life Sciences assists organizations developing pharmaceutical drugs, medical devices, and biotechnology with launching products and breaking into new markets quickly. Its proven solutions as well as professional and business services expedite the creation and delivery of consistent, compliant, high-quality and global content ? both physical and digital.

It boasts a rich 25+ year history of serving pharmaceutical producers, medical device manufacturers, and biotechnology companies.

For more information, go to www.amplexor.com/lifesciences.

 

SOURCE AMPLEXOR Life Sciences


These press releases may also interest you

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...

at 17:00
L.A. Care Health Plan and Blue Shield of California Promise Health Plan today held a grand opening ceremony for their Community Resource Center (CRC) in West Los Angeles (West L.A.) at 11173 W. Pico Blvd in Los Angeles....

at 16:55
Veterinary Management Groups (VMG) is proud to...

at 16:45
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered...



News published on and distributed by: